語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
FindBook
Google Book
Amazon
博客來
Prodromal Parkinson's Disease and Its Implications for Longitudinal Studies.
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Prodromal Parkinson's Disease and Its Implications for Longitudinal Studies./
作者:
Flores Torres, Mario H.
面頁冊數:
1 online resource (119 pages)
附註:
Source: Dissertations Abstracts International, Volume: 84-05, Section: B.
Contained By:
Dissertations Abstracts International84-05B.
標題:
Epidemiology. -
電子資源:
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29391765click for full text (PQDT)
ISBN:
9798357575975
Prodromal Parkinson's Disease and Its Implications for Longitudinal Studies.
Flores Torres, Mario H.
Prodromal Parkinson's Disease and Its Implications for Longitudinal Studies.
- 1 online resource (119 pages)
Source: Dissertations Abstracts International, Volume: 84-05, Section: B.
Thesis (Ph.D.)--Harvard University, 2022.
Includes bibliographical references
Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement abnormalities such as resting tremor, bradykinesia, and rigidity. In addition, non-motor symptoms such as decreased ability to smell, constipation, and sleep disorders are often present years before the clinical diagnosis of PD, also known as the prodromal period. PD affects close to one million Americans and its prevalence is expected to grow as the population ages. Existing treatments are not known to stop or slow the progression of the disease and few potential preventive factors have been proposed. The limited number of preventive factors may be due to the lack of large prospective studies with enough follow-up to enable the assessment of long-term exposures while accounting for the long prodromal phase of PD. In Chapter 1, we used data from 804 men participating in the Health Professionals' Follow-up Study (HPFS) to describe how experiencing combinations of hyposmia, constipation, and probable REM sleep behavior disorder (pRBD), common non-motor features of prodromal PD, are related to objective and subjective measures of cognitive function. In line with previous investigations, we found that the objective cognitive performance was worse in individuals with prodromal PD features, particularly among those with all 3 features, who are probably in the prodromal phase of PD. These men were also more likely to experience subjective cognitive decline (SCD) than men with no prodromal features encouraging further investigation of this marker. In Chapter 2, we used data from 12,427 women from the Nurses' Health Study (NHS), to examine whether SCD is more likely to be present in women with features suggestive of prodromal PD, compared to women without these features. Women experiencing the 3 examined non-motor features (hyposmia, constipation and pRBD) had the worst mean SCD score and the highest odds of poor subjective cognition. This association persisted when women with objective cognitive deficits were excluded from analyses. SCD was also more common in women with a probability of prodromal PD ≥ 0.80, based on the MDS score, particularly among those younger than 70 years. Our study suggests that SCD is common among individuals who are probably in the prodromal phase of PD. Our SCD assessment may be a time- and cost-efficient tool for large-scale screening for prodromal PD, particularly in combination with other prodromal markers and in younger populations. In Chapter 3, we leveraged longitudinal data from the NHS and HPFS collected over ~30 years of follow-up and investigated the association between long-term intake of folate, vitamin B6, and vitamin B12 with the subsequent occurrence of PD. We did not observe an association between intake of folate or vitamin B6 and the risk of PD. Results for vitamin B12 suggested a modest inverse association, particularly for baseline intake. Recent intake of folate, B6 and B12 supplements tended to be associated with higher PD risk, a trend consistent with reverse causality. Our study leaves open the possibility of a protective effect of vitamin B12 on the development of PD and highlights the implications of reverse causality when studying risk or protective factors for PD.
Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023
Mode of access: World Wide Web
ISBN: 9798357575975Subjects--Topical Terms:
568544
Epidemiology.
Subjects--Index Terms:
Parkinson's diseaseIndex Terms--Genre/Form:
542853
Electronic books.
Prodromal Parkinson's Disease and Its Implications for Longitudinal Studies.
LDR
:04475nmm a2200337K 4500
001
2359825
005
20230917195257.5
006
m o d
007
cr mn ---uuuuu
008
241011s2022 xx obm 000 0 eng d
020
$a
9798357575975
035
$a
(MiAaPQ)AAI29391765
035
$a
AAI29391765
040
$a
MiAaPQ
$b
eng
$c
MiAaPQ
$d
NTU
100
1
$a
Flores Torres, Mario H.
$3
3700440
245
1 0
$a
Prodromal Parkinson's Disease and Its Implications for Longitudinal Studies.
264
0
$c
2022
300
$a
1 online resource (119 pages)
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
500
$a
Source: Dissertations Abstracts International, Volume: 84-05, Section: B.
500
$a
Advisor: Ascherio, Alberto.
502
$a
Thesis (Ph.D.)--Harvard University, 2022.
504
$a
Includes bibliographical references
520
$a
Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement abnormalities such as resting tremor, bradykinesia, and rigidity. In addition, non-motor symptoms such as decreased ability to smell, constipation, and sleep disorders are often present years before the clinical diagnosis of PD, also known as the prodromal period. PD affects close to one million Americans and its prevalence is expected to grow as the population ages. Existing treatments are not known to stop or slow the progression of the disease and few potential preventive factors have been proposed. The limited number of preventive factors may be due to the lack of large prospective studies with enough follow-up to enable the assessment of long-term exposures while accounting for the long prodromal phase of PD. In Chapter 1, we used data from 804 men participating in the Health Professionals' Follow-up Study (HPFS) to describe how experiencing combinations of hyposmia, constipation, and probable REM sleep behavior disorder (pRBD), common non-motor features of prodromal PD, are related to objective and subjective measures of cognitive function. In line with previous investigations, we found that the objective cognitive performance was worse in individuals with prodromal PD features, particularly among those with all 3 features, who are probably in the prodromal phase of PD. These men were also more likely to experience subjective cognitive decline (SCD) than men with no prodromal features encouraging further investigation of this marker. In Chapter 2, we used data from 12,427 women from the Nurses' Health Study (NHS), to examine whether SCD is more likely to be present in women with features suggestive of prodromal PD, compared to women without these features. Women experiencing the 3 examined non-motor features (hyposmia, constipation and pRBD) had the worst mean SCD score and the highest odds of poor subjective cognition. This association persisted when women with objective cognitive deficits were excluded from analyses. SCD was also more common in women with a probability of prodromal PD ≥ 0.80, based on the MDS score, particularly among those younger than 70 years. Our study suggests that SCD is common among individuals who are probably in the prodromal phase of PD. Our SCD assessment may be a time- and cost-efficient tool for large-scale screening for prodromal PD, particularly in combination with other prodromal markers and in younger populations. In Chapter 3, we leveraged longitudinal data from the NHS and HPFS collected over ~30 years of follow-up and investigated the association between long-term intake of folate, vitamin B6, and vitamin B12 with the subsequent occurrence of PD. We did not observe an association between intake of folate or vitamin B6 and the risk of PD. Results for vitamin B12 suggested a modest inverse association, particularly for baseline intake. Recent intake of folate, B6 and B12 supplements tended to be associated with higher PD risk, a trend consistent with reverse causality. Our study leaves open the possibility of a protective effect of vitamin B12 on the development of PD and highlights the implications of reverse causality when studying risk or protective factors for PD.
533
$a
Electronic reproduction.
$b
Ann Arbor, Mich. :
$c
ProQuest,
$d
2023
538
$a
Mode of access: World Wide Web
650
4
$a
Epidemiology.
$3
568544
650
4
$a
Mental health.
$3
534751
653
$a
Parkinson's disease
655
7
$a
Electronic books.
$2
lcsh
$3
542853
690
$a
0766
690
$a
0347
710
2
$a
ProQuest Information and Learning Co.
$3
783688
710
2
$a
Harvard University.
$b
Population Health Sciences.
$3
3560571
773
0
$t
Dissertations Abstracts International
$g
84-05B.
856
4 0
$u
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29391765
$z
click for full text (PQDT)
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9482181
電子資源
11.線上閱覽_V
電子書
EB
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入